We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Algerian Cancer Center Installs Advanced Radiotherapy Equipment

By HospiMedica International staff writers
Posted on 07 Feb 2013
Cancer patients will gain access to more advanced treatments when three cutting-edge treatment linear accelerators are installed at a new radiotherapy department in Setif (Algeria) in the spring of 2012. More...


Algeria is experiencing an increase in cancer incidence, driven by the growth and ageing of its population as well as a high incidence of smoking. The World Health Organization’s (WHO; Geneva, Switzerland) GloboCan project indicates that in 2008, Algeria had 28,736 cancer cases. This is projected to rise to 35,628 in 2015, an increase of almost 25%. Lung and breast cancers are two of the most common cancers in Algeria, accounting for over a quarter of new cancer cases every year.

The Algerian Ministry of Health has ordered three from Varian Medical Systems (Palo Alto, CA, USA) medical linear accelerators as part of a major government initiative to equip the country with sophisticated radiotherapy systems.

The Varian Clinac iX devices, along with Eclipse treatment planning software and Aria oncology information-management software, will enable clinicians at the newly constructed facility to deliver advanced treatments such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT).

“We are pleased to be part of the Algerian Ministry of Health’s program to make modern cancer treatments accessible to more patients,” said Dow Wilson, Varian’s chief executive officer. “Varian has successfully improved the precision and speed of radiotherapy and radiosurgery in order to make it both a cost-effective and widely-available weapon in the war on cancer.”

Related Links:
Varian Medical Systems


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.